Objective. Rates of chronic non-cancer pain are increasing worldwide, with concerns regarding poorer access to specialist treatment services in remote areas. The current study comprised the first in-depth examination of use and barriers to access of health services in Australia according to remoteness. Methods. A cohort of Australian adults prescribed pharmaceutical opioids for chronic non-cancer pain (n = 1,235) were interviewed between August 2012 and April 2014, and grouped into 'major city' (49%), 'inner regional' (37%), and 'outer regional/remote' (14%) according to the Australian Standard Geographical Classification based on postcode. Multinomial logistic regression analyses were conducted to determine geographical differences in socio-demographic and clinical characteristics, health service use, and perceived barriers to health service access. Results. The 'inner regional group' and 'outer regional/remote group' were more likely to be male (relative risk ratio (RRR)=1.38,95%CI 1.08-1.77 and RRR = 1.60, 95%CI 1.14-2.24) and have no private health insurance (RRR = 1.53, 95%CI 1.19-1.97 and RRR = 1.65, 95%CI 1.16-2.37) than the 'major city group' (49%). However, the 'inner regional group' reported lower pain severity and better mental health relative to the 'major city group' = 0.92, 95%CI 0.86-0.98 and RRR = 1.02, 95%CI 1.01-1.03, respectively). Although rates of health service access were generally similar, the 'outer regional/remote group' were more likely to report client-practitioner communication problems (RRR = 1.57, 95%CI 1.03-2.37), difficulties accessing specialists (RRR = 1.56, 95%CI 1.01-2.39), and perception of practitioner lack of confidence in prescribing pain medication (RRR = 1.73, 1.14-2.62), relative to both groups. Conclusion. Perceived communication, access, and financial barriers to healthcare indicate the need for increased efforts to address geographic inequality in pain treatment. confidence in prescribing pain medication (RRR=1.73, 1.14-2.62), relative to both groups. 
Introduction

53
In Australia, chronic pain is estimated to affect nearly 20% of the adult population (2-5).
54
Chronic non-cancer pain (CNCP) reduces quality of life and impairs physical functioning, 55 sleep, mood, ability to work, and activities of daily living (e.g., walking, shopping) (6, 7), 56 with an estimated cost of AUD$34 billion nationally per annum in Australia (4). Treatments 57 that reduce pain severity and interference can mitigate some of these negative consequences also available and demonstrate some efficacy in reducing pain (10) (11) (12) . As such, current 64 guidelines typically emphasise a multi-disciplinary approach to treatment (13).
Methods
From a database of 5,745 community pharmacies, 1,868 were willing to refer potentially 121 eligible participants (19) . In total, 35% of pharmacies across all states and territories in 122 Australia agreed to participate. Of those potential participants who were referred (n=2,725), 123 1,873 were eligible, and a total of 1,514 completed the baseline POINT study interview (201 124 refused after being deemed eligible and 100 were unable to be contacted). Phone interviews 125 were conducted by research assistants who had a minimum 3-year health or psychology 126 degree. Interviewers had received training in the survey instrument and were provided 127 glossaries of chronic pain medications and conditions. Participants were included in the 128 analyses reported in this paper if they completed both the baseline telephone interview and 129 the self-complete measures including the medication diary (n=1,243); a further eight 130 participants were excluded as they did not provide their postcode (final sample n=1,235).
the PHQ-9 (24), symptoms of moderate to severe anxiety were defined as a score of ≥10 on 146 the GAD-7 (25). Post-traumatic stress disorder (PTSD) was measured using the Primary Care 147 PTSD screen (PC-PTSD); a score ≥ 3 was considered indicative of PTSD (26). 
Results
215
Sample Characteristics
216
The sample (n=1,235) had a median age of 59 and over half (57%) were female 217 (Table 1) . The majority had not completed tertiary education (64%), reported income 218 <AUD$400 (59%), and did not have private health insurance (63%), and nearly half (47%) 219 were currently unemployed. The most common CNCP conditions reported by the sample 220 were chronic neck/back problems (79%), followed by arthritis/rheumatism (68%), and 221 frequent/severe headaches (45%) ( 
Clinical Characteristics
235
The duration of living with CNCP and the rate of various CNCP conditions were similar 236 across the geographical remoteness groups (Table 1 ). The 'Inner Regional group' reported 237 lower BPI Severity scores, had better mental functioning and wellbeing (as scored on the SF-238 12), and tended to report lower relative risk of exceeding PHQ-9 and GAD-7 score cut-offs indicative of current moderate-to-severe depression and anxiety respectively, compared to the 
Medication Use
243
Univariate analyses showed that the groups were similar in regards to length of time in opioid 244 treatment (4 years on average), median opioid dose, and in the distribution of persons 245 receiving a high OME daily dose (15% of the sample ≥200mg/day) ( Table 1 ). The 'Inner
246
Regional group' had greater relative risk of currently using fentanyl and lower relative risk of 247 using oxycodone and prescription codeine in the past month, and the 'Outer Regional/Remote 248 group' had greater relative risk of using morphine in the past month, as compared to the 
Health Service Access
252
The majority of the sample had seen a GP in the past month (95%) on a median of two 253 occasions, with no significant difference between the geographical remoteness groups in the 254 number of visits (Table 2) . Rates of past month ambulance and emergency department 255 access, and hospital-based day procedures were also similar across the remoteness groups; 256 past month use was 7%, 12%, and 11% of the total sample for each service, respectively. As 257 compared to the 'Major City group', the 'Inner Regional group' had a lower relative risk of 258 accessing physiotherapy and mental health services for chronic pain in the past month; these 259 associations were not statistically significant following multivariate analyses. The 'Inner Regional/Remote group' showed that the latter were more likely to report that that they: i) felt In regards to treatment, the 'Inner Regional group' were more likely to be prescribed fentanyl 329 and less likely to be prescribed oxycodone and prescription codeine, and the 'Outer 
Strengths and Limitations
365
The POINT cohort comprises the largest sample of people with CNCP interviewed in were female (the POINT cohort was 55% female); and 7% were 18-34 years, 55% 35-64 years and 38% 65+ years (vs. 5%, 62% and 33% respectively, in the POINT cohort). Of these 378 customers, 63% were prescribed oxycodone (vs. 62% in the POINT sample), 16.5% 379 prescribed morphine (vs. 15% in the POINT cohort), 21% prescribed fentanyl patches (vs.
380
15% in the POINT cohort) and 24% prescribed buprenorphine patches (vs. 21% in the 381 POINT cohort). Although it is not possible to determine whether all the opioid customers 382 recorded by these pharmacists had been taking these opioids for chronic pain, and for six 383 weeks or more, the similarities are reassuring. It should be noted a similar geographical 384 breakdown was evident for those participants who were excluded who had provided a 385 postcode ('major cities': 51%; inner regional: 36%; outer regional: 13%) to the final sample 386 used in the present study. It should be noted that those participants excluded due to not 387 completing core measures relevant to this study were more likely to be male (51% versus 
Conclusion
399
Despite similar self-reported rates of health service access, participants in outer regional and 400 remote areas were more likely to cite communication problems and lack of confidence in 401 their doctor in treating CNCP, difficulties accessing specialists, and difficulties affording opioid medication. In order to achieve "knowledgeable, empowered, and supported 
